Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks.
Aedo, Sócrates
Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks. [electronic resource] - Menopause (New York, N.Y.) Dec 2015 - 1317-22 p. digital
Publication Type: Journal Article
1530-0374
10.1097/GME.0000000000000472 doi
Breast Neoplasms--mortality
Colorectal Neoplasms--mortality
Coronary Disease--mortality
Estrogen Replacement Therapy--adverse effects
Estrogens, Conjugated (USP)--administration & dosage
Female
Hip Fractures--mortality
Humans
Medroxyprogesterone Acetate--administration & dosage
Monte Carlo Method
Placebos
Proportional Hazards Models
Pulmonary Embolism--mortality
Randomized Controlled Trials as Topic
Risk Factors
Stroke--mortality
Survival Rate
Women's Health
Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks. [electronic resource] - Menopause (New York, N.Y.) Dec 2015 - 1317-22 p. digital
Publication Type: Journal Article
1530-0374
10.1097/GME.0000000000000472 doi
Breast Neoplasms--mortality
Colorectal Neoplasms--mortality
Coronary Disease--mortality
Estrogen Replacement Therapy--adverse effects
Estrogens, Conjugated (USP)--administration & dosage
Female
Hip Fractures--mortality
Humans
Medroxyprogesterone Acetate--administration & dosage
Monte Carlo Method
Placebos
Proportional Hazards Models
Pulmonary Embolism--mortality
Randomized Controlled Trials as Topic
Risk Factors
Stroke--mortality
Survival Rate
Women's Health